Natrecor (nesiritide), a new IV drug for treating patients who are hospitalized with acute CHF.

You'll soon see patients on Natrecor (nesiritide), a new IV drug for treating patients who are hospitalized with acute CHF.

It's in a new drug class...human B-type natriuretic peptide (hBNP).

Natrecor is a recombinant version of this peptide...and has vasodilatory and diuretic effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote